IRON Financial LLC Acquires 151 Shares of The Clorox Company (NYSE:CLX)

IRON Financial LLC grew its holdings in shares of The Clorox Company (NYSE:CLX) by 2.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 5,512 shares of the company’s stock after purchasing an additional 151 shares during the quarter. IRON Financial LLC’s holdings in Clorox were worth $895,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of CLX. Brooklyn Investment Group grew its holdings in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new position in shares of Clorox during the third quarter valued at about $27,000. Continuum Advisory LLC boosted its position in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Quarry LP grew its stake in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new stake in Clorox in the 3rd quarter valued at about $48,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock opened at $162.35 on Tuesday. The business’s fifty day simple moving average is $163.66 and its 200 day simple moving average is $157.66. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market capitalization of $20.10 billion, a P/E ratio of 56.57, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the firm earned $0.49 EPS. The firm’s quarterly revenue was up 27.0% on a year-over-year basis. As a group, analysts anticipate that The Clorox Company will post 6.87 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.01%. Clorox’s payout ratio is currently 170.04%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Finally, Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and upped their target price for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.